FDA Sues NJ Compounder Over Mold-Contaminated Products
The U.S. Food and Drug Administration on Friday slapped drug compounding facility Med Prep Consulting Inc. and its senior executive with a lawsuit in New Jersey federal court for circulating intravenous...To view the full article, register now.
Already a subscriber? Click here to view full article